Cargando…
Bayesian hierarchical meta‐analytic methods for modeling surrogate relationships that vary across treatment classes using aggregate data
Surrogate endpoints play an important role in drug development when they can be used to measure treatment effect early compared to the final clinical outcome and to predict clinical benefit or harm. Such endpoints are assessed for their predictive value of clinical benefit by investigating the surro...
Autores principales: | Papanikos, Tasos, Thompson, John R., Abrams, Keith R., Städler, Nicolas, Ciani, Oriana, Taylor, Rod, Bujkiewicz, Sylwia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065251/ https://www.ncbi.nlm.nih.gov/pubmed/31990083 http://dx.doi.org/10.1002/sim.8465 |
Ejemplares similares
-
Use of copula to model within‐study association in bivariate meta‐analysis of binomial data at the aggregate level: A Bayesian approach and application to surrogate endpoint evaluation
por: Papanikos, Tasos, et al.
Publicado: (2022) -
Bayesian meta‐analytical methods to incorporate multiple surrogate endpoints in drug development process
por: Bujkiewicz, Sylwia, et al.
Publicado: (2015) -
Using Bayesian Evidence Synthesis Methods to Incorporate Real-World Evidence in Surrogate Endpoint Evaluation
por: Wheaton, Lorna, et al.
Publicado: (2023) -
Uncertainty in the Bayesian meta-analysis of normally distributed surrogate endpoints
por: Bujkiewicz, Sylwia, et al.
Publicado: (2015) -
Bivariate network meta‐analysis for surrogate endpoint evaluation
por: Bujkiewicz, Sylwia, et al.
Publicado: (2019)